Progress on individualized drug therapy for older men under the benign prostatic hyperplasia/urinary tract symptoms

Lower urinary tract symptoms due to benign prostatic hyperplasia is of great prevalence among ageing males, and it can markedly affect patients′ quality of life.Personalized drug therapy according to genetic characteristics is the ideal choice for this problem.Here we summarized the latest research findings on the associations of gene polymorphisms with drug efficacy and adverse reaction in the treatment of benign prostatic hyperplasia/urinary tract symptoms. Key words: Prostatic hyperplasia; Drug Therapy; Individualized medicine